{"entity":{"type":"insider","cik":"0001471149","url":"/insider/0001471149","json_url":"/insider/0001471149.json","name":"Ayer Capital Management, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2011-06-27","last":"2015-05-08","span_basis":"filed_date"},"name_variants":[{"name":"Ayer Capital Management, LP","source":"filing","n_filings":4,"first_seen":"2011-06-27","last_seen":"2015-05-08"}],"transactions":[{"id":8148992,"accession":"0001140361-15-018423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-018423","line_url":"/filing/0001140361-15-018423#line-1","is_derivative":false,"issuer_cik":"0001425205","issuer_name":"Lion Biotechnologies, Inc.","issuer_ticker":"LBIO","issuer_name_source":null,"issuer_url":"/issuer/0001425205","owner_cik":null,"owner_name":"ACM Capital Partners, LLC; Ayer Capital Management, LP; Ayer Capital Partners, LLC","owner_display_name":"ACM Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2780682.0,"shares_display":"2,780,682","price_per_share":9.6208,"price_display":"9.62","price_state":"stated","total_value":26752385.3856,"total_display":"26,752,385.39","total_whole":"26,752,385","shares_owned_after":2823333.0,"shares_owned_after_display":"2,823,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-01","filed_date":"2015-05-08","scope":"insider"},{"id":3497184,"accession":"0001140361-12-031724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-031724","line_url":"/filing/0001140361-12-031724#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ACCESS PHARMACEUTICALS INC","issuer_ticker":"ACCP","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Ayer Capital Partners, LLC; Ayer Capital Management, LP; Venkatesan Jay; ACM Capital Partners, LLC","owner_display_name":"Ayer Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":179157.0,"shares_display":"179,157","price_per_share":0.553,"price_display":"0.55","price_state":"stated","total_value":99073.821,"total_display":"99,073.82","total_whole":"99,074","shares_owned_after":2413163.0,"shares_owned_after_display":"2,413,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-29","filed_date":"2012-06-29","scope":"insider"},{"id":3497180,"accession":"0001140361-12-031724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-031724","line_url":"/filing/0001140361-12-031724#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ACCESS PHARMACEUTICALS INC","issuer_ticker":"ACCP","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Ayer Capital Partners, LLC; Ayer Capital Management, LP; Venkatesan Jay; ACM Capital Partners, LLC","owner_display_name":"Ayer Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.675,"price_display":"0.68","price_state":"stated","total_value":16875.0,"total_display":"16,875.00","total_whole":"16,875","shares_owned_after":2592320.0,"shares_owned_after_display":"2,592,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-28","filed_date":"2012-06-29","scope":"insider"},{"id":2262373,"accession":"0001140361-12-025869","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-025869","line_url":"/filing/0001140361-12-025869#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ACCESS PHARMACEUTICALS INC","issuer_ticker":"ACCP","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"ACM Capital Partners, LLC; Ayer Capital Management, LP; Ayer Capital Partners, LLC; Venkatesan Jay","owner_display_name":"ACM Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140300.0,"shares_display":"140,300","price_per_share":0.67,"price_display":"0.67","price_state":"stated","total_value":94001.0,"total_display":"94,001.00","total_whole":"94,001","shares_owned_after":2617320.0,"shares_owned_after_display":"2,617,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-16","filed_date":"2012-05-16","scope":"insider"},{"id":2262368,"accession":"0001140361-12-025869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-025869","line_url":"/filing/0001140361-12-025869#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ACCESS PHARMACEUTICALS INC","issuer_ticker":"ACCP","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"ACM Capital Partners, LLC; Ayer Capital Management, LP; Ayer Capital Partners, LLC; Venkatesan Jay","owner_display_name":"ACM Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":850.0,"total_display":"850.00","total_whole":"850","shares_owned_after":2757620.0,"shares_owned_after_display":"2,757,620","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-15","filed_date":"2012-05-16","scope":"insider"},{"id":8832321,"accession":"0001140361-11-034328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-034328","line_url":"/filing/0001140361-11-034328#line-2","is_derivative":false,"issuer_cik":"0001412067","issuer_name":"Oncothyreon Inc.","issuer_ticker":"ONTY","issuer_name_source":null,"issuer_url":"/issuer/0001412067","owner_cik":"0001471149","owner_name":"Ayer Capital Management, LP","owner_display_name":"Ayer Capital Management, LP","owner_url":"/insider/0001471149","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28900.0,"shares_display":"28,900","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":252586.0,"total_display":"252,586.00","total_whole":"252,586","shares_owned_after":2985238.0,"shares_owned_after_display":"2,985,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-23","filed_date":"2011-06-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001425205","name":"Lion Biotechnologies, Inc.","url":"/issuer/0001425205","role":"Ten percent owner","n_filings":1,"first_seen":"2015-05-08","last_seen":"2015-05-08"},{"type":"issuer","type_label":"ISSUER","cik":"0000318306","name":"ACCESS PHARMACEUTICALS INC","url":"/issuer/0000318306","role":"Ten percent owner","n_filings":2,"first_seen":"2012-05-16","last_seen":"2012-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001412067","name":"Oncothyreon Inc.","url":"/issuer/0001412067","role":"Ten percent owner","n_filings":1,"first_seen":"2011-06-27","last_seen":"2011-06-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001471149","retrieved_at":"2026-08-23T15:17:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}